Skip to main content
SpringerLink
Log in

Ponatinib

Cerebral vasospam: case report

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Bassil R, et al. Cerebral vasospasm and infarction associated with CML treatment with ponatinib. Neurocritical Care 29 (Suppl.): S207 abstr. 261, No. 1, Jan 2018. Available from: URL: http://doi.org/10.1007/s12028-018-0606-9 [abstract]

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ponatinib. Reactions Weekly 1808, 258 (2020). https://doi.org/10.1007/s40278-020-79735-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-020-79735-7

Search

Navigation